SN
Subbu Nambi Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
38
Avg Return
Past Year
Past Year
17%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
92.9%
Neutral
7.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Industrials
Healthcare
Biotechnology
Diagnostics & Research
Health Information Services
Medical Devices
Medical Instruments & Supplies
Industrials
Integrated Freight & Logistics
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $12 |
30%
upside
| 1 | +32% |
0
%
| 9 Jan ‘26 8 days ago |
|
|
|
Buy
Maintained
| $50 |
20%
upside
| 2 | +3.5% |
0
%
| 5 Jan ‘26 12 days ago |
|
|
|
Buy
Maintained
| $270 |
17%
upside
| 1 | +1.1% |
0
%
| 5 Jan ‘26 12 days ago |
|
|
|
Buy
Maintained
| $144 |
2%
upside
| 1 | +13% |
0
%
| 5 Jan ‘26 12 days ago |
|
|
|
Buy
Maintained
| $115 |
3%
upside
| 1 | +29% |
0
%
| 5 Jan ‘26 12 days ago |
|
|
|
Buy
Maintained
| $275 |
17%
upside
| 1 | +7.5% |
0
%
| 5 Jan ‘26 12 days ago |
|
|
|
Buy
Maintained
| $43 |
7%
upside
| 1 | +3.8% |
0
%
| 5 Jan ‘26 12 days ago |
|
|
|
Buy
Maintained
| $53 |
10%
upside
| 1 | -2.4% |
0
%
| 5 Jan ‘26 12 days ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | +52% |
0
%
| 21 Nov ‘25 1 month ago |
|
|
|
Buy
Upgraded
| $100 |
3%
upside
| 1 | +16% |
0
%
| 12 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $12 |
21%
upside
| 1 | +15% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $170 |
57%
upside
| 1 | +15% |
0
%
| 29 Oct ‘25 2 months ago |
|